APA (7th ed.) Citation

Scherrer, E. C., Ramos, K. A., Valadares, Y. M., Soares, I. G. M., Carli, A. P., Sá Silva, F., . . . Castro, S. B. R. (2025). Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation. Metabolic Brain Disease, 40(4), . https://doi.org/10.1007/s11011-025-01591-0

Chicago Style (17th ed.) Citation

Scherrer, Elaine Carlos, et al. "Ursolic Acid Derivatives Improved Clinical Signs of Experimental Autoimmune Encephalomyelitis by Modulating Central Nervous System Inflammation." Metabolic Brain Disease 40, no. 4 (2025). https://doi.org/10.1007/s11011-025-01591-0.

MLA (9th ed.) Citation

Scherrer, Elaine Carlos, et al. "Ursolic Acid Derivatives Improved Clinical Signs of Experimental Autoimmune Encephalomyelitis by Modulating Central Nervous System Inflammation." Metabolic Brain Disease, vol. 40, no. 4, 2025, https://doi.org/10.1007/s11011-025-01591-0.